Pia Munkholm
Clinical Professor
11 - 12 out of 12Page size: 10
- 2021
- Published
Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD
SPIRIT-IOIBD study group, S. S. G., 2021, In: Gastroenterology. 160, 5, p. 1452-1460Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases
Attauabi, M., Höglund, C., Fassov, J., Pedersen, K. B., Hansen, H. B., Wildt, S., Jensen, M. D., Neumann, A., Lind, C., Jacobsen, H. A., Popa, A. M., Kjeldsen, J., Pedersen, N., Molazahi, A., Haderslev, K., Aalykke, C., Knudsen, T., Cebula, W., Munkholm, P., Bendtsen, F. & 2 others, , 2021, In: Scandinavian Journal of Gastroenterology. 56, 9, p. 1040-1048Research output: Contribution to journal › Journal article › Research › peer-review
ID: 964362
Most downloads
-
244
downloads
Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
161
downloads
The complexity of evaluating and increasing adherence in inflammatory bowel disease
Research output: Contribution to journal › Editorial › Research
Published -
124
downloads
Inflammatory bowel diseases in Faroese-born Danish residents and their offspring: further evidence of the dominant role of environmental factors in IBD development
Research output: Contribution to journal › Journal article › Research › peer-review
Published